Revenue: As of FY2026 Q1, the actual value is USD 66.43 M.

EPS: As of FY2026 Q1, the actual value is USD -0.1.

EBIT: As of FY2026 Q1, the actual value is USD 11.97 M.

Revenue

Jushi Holdings Inc. reported revenue of $66.4 million for the first quarter ended March 31, 2026, an increase of $2.6 million compared to $63.8 million in the first quarter of 2025. Retail revenue increased by $1.0 million, and wholesale revenue increased by $1.6 million .

Gross Profit and Gross Margin

Gross profit for Q1 2026 was $29.9 million, with a gross profit margin of 45.0%. This marks an increase from $25.8 million and 40.4%, respectively, in Q1 2025 .

Net Loss

Jushi Holdings Inc. reported a net loss of -$19.8 million for Q1 2026, compared to a net loss of -$17.0 million in Q1 2025 .

Operating Profit and Operating Margin

Income from operations was $1.6 million in Q1 2026, a significant improvement from a loss from operations of -$1.9 million in Q1 2025 .

Operating Costs

Operating expenses were $28.3 million in Q1 2026, a modest increase from $27.6 million in Q1 2025 .

Adjusted EBITDA and Adjusted EBITDA Margin

Adjusted EBITDA was $11.4 million for Q1 2026, with an Adjusted EBITDA margin of 17.2%. This compares to Adjusted EBITDA of $9.8 million and an Adjusted EBITDA margin of 15.4% in Q1 2025 .

Cash Flow

Net cash flows provided by operations were $8.6 million during Q1 2026, up from $7.5 million during Q1 2025 .

Balance Sheet and Liquidity

As of March 31, 2026, Jushi Holdings Inc. had $42.3 million in cash, cash equivalents, and restricted cash. Capital expenditures during Q1 2026 were approximately $3.0 million . Total gross debt subject to scheduled repayments was $222.1 million as of March 31, 2026. The company completed a strategic refinancing in March 2026, issuing a $160.0 million secured term loan due in 2029 to repay previous debts totaling approximately $132.3 million .

Operational Metrics

Jushi Holdings Inc. ended Q1 2026 with forty-two dispensaries in eight states, an increase from forty dispensaries in seven states at the end of Q1 2025. Jushi-branded product sales accounted for 58% of retail revenue in Q1 2026 across the company’s five vertical markets, up from 56% in Q1 2025. The company introduced 567 new, unique SKUs in Q1 2026. As of May 5, 2026, the company had 199,696,597 issued and outstanding shares and 305,626,935 fully diluted shares outstanding .

Outlook / Guidance

Jushi Holdings Inc. expects a positive impact on its tax expense due to the rescheduling of state-licensed medical marijuana to Schedule III, which eliminates Section 280E application for such operations. A formal hearing on potential further rescheduling of marijuana to Schedule III is scheduled for June 29th through July 15th. The company is also monitoring adult-use cannabis legislation in Virginia, which could expand its customer base and increase demand, though the timing and extent of revenue impact remain uncertain .